Correlation Between Riber SA and Abionyx Pharma
Can any of the company-specific risk be diversified away by investing in both Riber SA and Abionyx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Riber SA and Abionyx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Riber SA and Abionyx Pharma SA, you can compare the effects of market volatilities on Riber SA and Abionyx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Riber SA with a short position of Abionyx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Riber SA and Abionyx Pharma.
Diversification Opportunities for Riber SA and Abionyx Pharma
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Riber and Abionyx is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Riber SA and Abionyx Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abionyx Pharma SA and Riber SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Riber SA are associated (or correlated) with Abionyx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abionyx Pharma SA has no effect on the direction of Riber SA i.e., Riber SA and Abionyx Pharma go up and down completely randomly.
Pair Corralation between Riber SA and Abionyx Pharma
Assuming the 90 days trading horizon Riber SA is expected to generate 0.76 times more return on investment than Abionyx Pharma. However, Riber SA is 1.31 times less risky than Abionyx Pharma. It trades about 0.05 of its potential returns per unit of risk. Abionyx Pharma SA is currently generating about -0.01 per unit of risk. If you would invest 157.00 in Riber SA on August 24, 2024 and sell it today you would earn a total of 99.00 from holding Riber SA or generate 63.06% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Riber SA vs. Abionyx Pharma SA
Performance |
Timeline |
Riber SA |
Abionyx Pharma SA |
Riber SA and Abionyx Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Riber SA and Abionyx Pharma
The main advantage of trading using opposite Riber SA and Abionyx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Riber SA position performs unexpectedly, Abionyx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abionyx Pharma will offset losses from the drop in Abionyx Pharma's long position.Riber SA vs. Kalray SA | Riber SA vs. Lacroix Group SA | Riber SA vs. Ekinops SA | Riber SA vs. Plastiques du Val |
Abionyx Pharma vs. Biophytis SA | Abionyx Pharma vs. Gensight Biologics SA | Abionyx Pharma vs. OSE Pharma SA | Abionyx Pharma vs. Abivax SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements |